-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Tvardi Therapeutics, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2012 to Q3 2025.
- Tvardi Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.000.
- Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2018 was $0.000.
- Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2017 was $0.000.
- Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2016 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)